TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07640191: Feasibility Study of the iVEAcare Neuromodulation System for the Treatment of Drug-Resistant Epilepsy

Sponsor: iVEAcare · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 30 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$4,112,800

Rescue Site Savings

+$2,716,000

Unlock Full NCT07640191 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07640191 Rescue Dossier →